PAPER Azimova RK, Kagan BL
SEARCH RESULTS
331008 RESULTS
Marta Rolland
grenoble, France
PAPER Yesuvadian R, Krishnamoorthy J, Ramamoorthy A, Bhunia A
Potent γ-secretase inhibitors/modulators interact with amyloid-β fibrils but do not inhibit fibrillation: a high-resolution NMR study.
Biochem Biophys Res Commun. 2014 May 16;447(4):590-5. Epub 2014 Apr 18 PubMed: 24747079PAPER Liu P, Sun L, Zhao XL, Zhang P, Zhao XM, Zhang J
PAR2-mediated epigenetic upregulation of α-synuclein contributes to the pathogenesis of Parkinson׳s disease.
Brain Res. 2014 May 27;1565:82-9. Epub 2014 Apr 18 PubMed: 24747612PAPER Savolainen MH, Richie CT, Harvey BK, Männistö PT, Maguire-Zeiss KA, Myöhänen TT
The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse.
Neurobiol Dis. 2014 Aug;68:1-15. Epub 2014 Apr 16 PubMed: 24746855PAPER Pasanen P, Myllykangas L, Siitonen M, Raunio A, Kaakkola S, Lyytinen J, Tienari PJ, Pöyhönen M, Paetau A
A novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology.
Neurobiol Aging. 2014 Sep;35(9):2180.e1-5. Epub 2014 Mar 26 PubMed: 24746362PAPER Hardy J, Bogdanovic N, Winblad B, Portelius E, Andreasen N, Cedazo-Minguez A, Zetterberg H
Pathways to Alzheimer's disease.
J Intern Med. 2014 Mar;275(3):296-303. PubMed: 24749173PAPER Galvin JE, Tolea MI, George N, Wingbermuehle C
Public-private partnerships improve health outcomes in individuals with early stage Alzheimer's disease.
Clin Interv Aging. 2014;9:621-30. Epub 2014 Apr 10 PubMed: 24748780PAPER Werner P, Heinik J, Giveon S, Segel-Karpas D, Kitai E
Help-seeking preferences in the area of mild cognitive impairment: comparing family physicians and the lay public.
Clin Interv Aging. 2014;9:613-9. Epub 2014 Apr 9 PubMed: 24748779PAPER Mormino EC, Betensky RA, Hedden T, Schultz AP, Ward A, Huijbers W, Rentz DM, Johnson KA, Sperling RA, Alzheimer's Disease Neuroimaging Initiative, Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing, Harvard Aging Brain Study
Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.
Neurology. 2014 May 20;82(20):1760-7. Epub 2014 Apr 18 PubMed: 24748674PAPER Ossenkoppele R, van der Flier WM, Verfaillie SC, Vrenken H, Versteeg A, van Schijndel RA, Sikkes SA, Twisk J, Adriaanse SM, Zwan MD, Boellaard R, Windhorst AD, Barkhof F, Scheltens P, Lammertsma AA, van Berckel BN
Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions.
Neurology. 2014 May 20;82(20):1768-75. Epub 2014 Apr 18 PubMed: 24748672PAPER Knopman DS
β-Amyloidosis and neurodegeneration in Alzheimer disease: who's on first?
Neurology. 2014 May 20;82(20):1756-7. Epub 2014 Apr 18 PubMed: 24748669PAPER Saiz-Sanchez D, De la Rosa-Prieto C, Ubeda-Banon I, Martinez-Marcos A
Interneurons, tau and amyloid-β in the piriform cortex in Alzheimer's disease.
Brain Struct Funct. 2014 Apr 19; PubMed: 24748561PAPER Rudrabhatla P
Regulation of neuronal cytoskeletal protein phosphorylation in neurodegenerative diseases.
J Alzheimers Dis. 2014;41(3):671-84. PubMed: 24748119PAPER Brandner S, Thaler C, Lelental N, Buchfelder M, Kleindienst A, Maler JM, Kornhuber J, Lewczuk P
Ventricular and lumbar cerebrospinal fluid concentrations of Alzheimer's disease biomarkers in patients with normal pressure hydrocephalus and posttraumatic hydrocephalus.
J Alzheimers Dis. 2014;41(4):1057-62. PubMed: 24748118Current Filters
No filters selected